Sleep medicineHumansSleep ApneaObstructiveParkinson DiseaseBiomarkers
Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkinson's disease: Longitudinal effects of CPAP therapy.
Shasha Zhu, Di An, Xiaoxi Liu
Published: 202610.1016/j.sleep.2026.108766
Abstract
BACKGROUND: Obstructive sleep apnea (OSA) is common in Parkinson's disease (PD) and may exacerbate neurodegeneration via inflammatory and glial mechanisms, yet longitudinal biomarker data are scarce. We aimed to compare inflammatory, glial, and neuro…
Preview only. Read the full abstract at the source